LD-2 disclosure · 4th Quarter - Report
ALLERGAN USA, INC.
via ALLERGAN USA, INC.
Client
- Name
- ALLERGAN USA, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- ALLERGAN USA, INC.
- Description
- Pharmaceutical development and manufacturing
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesPharmacy
Supporting proposals to strengthen cGMP; encouraging full implementation and enforcement of the Drug Quality and Safety Act.
LobbyistsROBERT W. LIVELY · DANIEL M HARDER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Taxation/Internal Revenue Code
Issues relating to tax moratoriums for medical devices.
LobbyistsROBERT W. LIVELY · DANIEL M HARDER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Medicare/Medicaid
Proposals to maintain and strengthen patient access to needed prescription medicine and medical devices under the Medicare and Medicaid programs; advocacy for access to personalized treatment options for low income populations; supporting regulations to empower health care decisions between health care providers and patients; issues related to Administration actions which would allow patients to save out-of-pocket expenses on their prescription drugs.
LobbyistsROBERT W. LIVELY · DANIEL M HARDER